A preclinical study conducted at the Institute of Oncology Research (IOR, affiliated to USI Università dellaSvizzera italiana) reveals the role of aging cells in the formation of metastases and identifies a drug capable of blocking them. The findings of the group of researchers in Switzerland, Italy and the United States, led by Prof. Andrea Alimonti, […]
